project id: TCGA-LUAD; case submitter id: TCGA-05-5425; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 68; days to birth: -25020; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1941; age at diagnosis: 25020; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 882.0; icd 10 code: C34.9; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lung, NOS; synchronous malignancy: No; tissue or organ of origin: Lung, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; years smoked: 20.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.9; longest dimension: 1.2; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-05-5425-01A-02; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent stromal cells: 0.0; percent tumor nuclei: 60.0;